Consistent with the predicted role of KDM5C as a transcriptional repressor through removing the histone activation marker H3K4me3, our results revealed that FASN is targeted directly by KDM5C during the progression of ICC. Here, FASN is linked to intrahepatic cholangiocarcinoma.